PDCD1 and neoplasm: Depletion of β3-integrin elicited an abscopal immunotherapeutic effect measured as protection from the challenge tumor and durable splenocyte and serum reactivity to tumor antigens, providing the rationale for combinatorial immunotherapeutic approaches with PD-1/PD-L1 axis inhibitors.